$20.270
+1.119 (+5.52%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
Braveheart Bio, Inc. 株は買うべき？
Braveheart Bio, Inc. is not a good buy right now due to significant financial losses and negative price momentum. The current price is $18.71, with a recent 5-day change of -6.54% and a year-to-date change of only +3.94%. The company's net loss for Q2 2026 was $18.60 million, up from $0.38 million the previous year, indicating worsening financial health. Additionally, the RSI is at 32.844, suggesting the stock is oversold, but this may not be enough to justify a buy given the ongoing losses and high clinical development costs.
BRVE の株価は Tuesday に $20.27 で引け、その前に上昇 +5.52%
Braveheart Bio, Inc. (BRVE) last closed at $20.27, gaining +5.52%. These facts feed the 1-day and 1-week BRVE price prediction above.
予想の要因
Braveheart Bio, Inc.（BRVE）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
BRVE の季節性分析
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。